Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis
Science Signaling · 2024
DOI: 10.1126/scisignal.abn8003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Julien Nadjar und 11 weiteren Autor:innen. Beteiligte Einrichtung: CRCL, Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Béra…. Hauptthemen laut MEDLINE: Pyroptosis, Inflammasomes, Optogenetics, CARD Signaling Adaptor Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: LLNC as “Equipe labellisée Ligue 2014”, Institut Convergence PLAsCAN, Fondation pour la Recherche Médicale as “équipe labellisée”.
Abstract (Originalsprache)
Inflammasomes are multiprotein platforms that control caspase-1 activation, which process the inactive precursor forms of the inflammatory cytokines IL-1β and IL-18, leading to an inflammatory type of programmed cell death called pyroptosis. Studying inflammasome-driven processes, such as pyroptosis-induced cell swelling, under controlled conditions remains challenging because the signals that activate pyroptosis also stimulate other signaling pathways. We designed an optogenetic approach using a photo-oligomerizable inflammasome core adapter protein, apoptosis-associated speck–like containing a caspase recruitment domain (ASC), to temporally and quantitatively manipulate inflammasome activation. We demonstrated that inducing the light-sensitive oligomerization of ASC was sufficient to recapitulate the classical features of inflammasomes within minutes. This system showed that there were two phases of cell swelling during pyroptosis. This approach offers avenues for biophysical investigations into the intricate nature of cellular volume control and plasma membrane rupture during cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CRCL, Centre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon 1, Centre Léon Bérard, F-69000 Lyon, France.
- Université de Lyon, Université Claude Bernard Lyon 1, CNRS, Institut Lumière Matière, F-69622, Villeurbanne, France.
- DYSAD, Institut pour l'avancée des biosciences (IAB), Centre de Recherche UGA / Inserm U 1209/CNRS UMR 5309, 38700 La Tronche, France.
- CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.
ORCID-Profile: Julien Nadjar, Sylvain Monnier, Estelle Bastien, Anne-Laure Huber, Christiane Oddou, Léa Bardoulet, Gabriel Ichim, Christophe Vanbelle, Bénédicte F Py, Olivier Destaing, Virginie Petrilli
Förderung
- LLNC as “Equipe labellisée Ligue 2014”
- Institut Convergence PLAsCAN
- Fondation pour la Recherche Médicale as “équipe labellisée”
- Agence Nationale de la Recherche (ANR) Young Researchers Project
- Marie Sklodowska-Curie fellowship
- fondation Line Pomaret Delalande
Zitieren
APA
Nadjar, J., Monnier, S., Bastien, E., Huber, A. L., Oddou, C., Bardoulet, L., Leloup, H. B., Ichim, G., Vanbelle, C., Py, B. F., Destaing, O., & Petrilli, V. (2024). Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis. Science Signaling. https://doi.org/10.1126/scisignal.abn8003
Vancouver
Nadjar J, Monnier S, Bastien E, Huber AL, Oddou C, Bardoulet L, et al. Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis. Science Signaling. 2024. doi:10.1126/scisignal.abn8003
BibTeX
@article{Nadjar2024,
author = {Nadjar, Julien and Monnier, Sylvain and Bastien, Estelle and Huber, Anne-Laure and Oddou, Christiane and Bardoulet, Léa and Leloup, Hubert B and Ichim, Gabriel and Vanbelle, Christophe and Py, Bénédicte F and Destaing, Olivier and Petrilli, Virginie},
title = {Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis},
journal = {Science Signaling},
year = {2024},
doi = {10.1126/scisignal.abn8003}
}
EUVIMED